While PD1/PD-L1 are upregulated in human and mouse tumors [22], including lung cancer cells (see Fig 1), the underlying mechanisms, particularly in the content of cisplatin resistance, remain elusive. The gene discussed is PDCD1; the disease is lung cancer.